Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: biotechnology law
Court Blocks Obama’s Stem Cell Order
In December of 2009, I argued that President Obama’s Executive Order 13505, that lifted President Bush’s 2001 Order banning the use of federal funds for embryonic stem cell (ESC) research, should be a Top Biotech Story of 2009. The Bush … Continue reading
University IP In The News – Expedited Examination And March-In Request
On July 29th, Rep. Frank Wolf (D.-Va.) introduced H.R. 5980 that would give priority to examination of patent applications filed by U.S. universities and by their “patent holding companies.” The definition of the latter seems a bit vague, but is … Continue reading
Posted in Tech Transfer
Tagged biotechnology, biotechnology law, biotechnology news, DHHS, Fabrazyme, Fabry Disease, Frank Wolf, H.R. 5980, intellectual property, ip, Patent Law, patents, WARF, Warren Woessner
Leave a comment
MYRAID APPEAL UPDATE: WHO’S RECUSING WHO?
Subtitle: “Who’s Your Amicus, Baby?” On July 19th, various Blogs reported that the ACLU (Plaintiffs’ attorney in the appeal of the district court’s ruling in the case sensibly abbreviated by Hal Wegner as AMP v PTO) filed a motion in … Continue reading
Testing The “Myriad Method Claims” Using The USPTO Interim Guidance – Beyond “M or T”?
In my last post, I discussed the contents of the USPTO’s “Interim Guidance for Determining Subject Matter Eligibility for Process Claims in View of Bilski v. Kappos.” One of the most intriguing single points for discussion comes at the end … Continue reading